Prosecution Insights
Last updated: November 12, 2026
Application No. 18/760,649

MAGNETIC THERAPY DEVICES AND RELATED METHODS

Non-Final OA §102§103§112§DOUBLEPATENT
Filed
Jul 01, 2024
Priority
Oct 03, 2018 — provisional 62/740,764 +2 more
Examiner
LANNU, JOSHUA DARYL DEANON
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Selfkaire Inc.
OA Round
1 (Non-Final)
82%
Grant Probability
Favorable
1-2
OA Rounds
99%
With Interview

Examiner Intelligence

Grants 82% — above average
82%
Career Allowance Rate
794 granted / 965 resolved
+12.3% vs TC avg
Strong +24% interview lift
Without
With
+23.9%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
29 currently pending
Career history
1005
Total Applications
across all art units

Office Action

§102 §103 §112 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after 3/16/13, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement (IDS) submitted on 9/27/2024 is being considered by the examiner. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “holding portion for controlling the magnetic therapy device” in claim 1. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Based on Applicant’s specification, the holding portion is element 110 (paragraph 34; figures 1-3), which is a handle. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-13 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 recites the limitation “the pins defining a cavity for receiving the pins”, which can be interpreted as a singular cavity that receives multiple pins and “magnets disposed within the cavity”, which can be interpreted as the cavity holding multiple magnets. There is no written disclosure for the configuration of a single cavity defined by multiple pins holding multiple magnets in the specification. Claims 2-13 inherit the deficiencies of claim 1 and are likewise rejected. Claim 6 recites the limitation “surgical steel” in lines 1-2. However, there is no formal definition in industry or definition in the disclosure as to what constitutes surgical steel The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation “the body” in line 8. There is insufficient antecedent basis for this limitation in the claim. It is noted that claims 7 and 8 recite the same limitation. Claim1 recites the limitation “the pins defining a cavity for receiving the pins” in lines 8-9. It is not clear how pins can define a cavity for receiving themselves. Claims 2-13 inherit the deficiencies of claim 1 and are likewise rejected. Claim 5 recites the limitation “less than or equal to 1 to 3 inches” in lines 2-3. It is not clear how some something can be less than or equal to a range. This should be amended to --less than or equal to 3 inches--. Claim 11 recites the limitation "a mounting portion" in line 2. It is not clear if this is a new instance or refers to the mounting portion in line 6 of claim 1. Claim 12 recites the limitation “the cavities of the pins” in line 2. There is insufficient antecedent basis for this limitation in the claim. Claim 13 recites the limitation “the cavities of the pins” in line 2. There is insufficient antecedent basis for this limitation in the claim. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1 and 14 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 and 2 of U.S. Patent No. 12,053,639. Although the claims at issue are not identical, they are not patentably distinct from each other because US 12,053,639 disclose species that anticipates the present genus claims. The mapping of the claims is as follows: Present Application US 12,053,639 1. A magnetic therapy device for treating a body part, comprising: a holding portion for controlling the magnetic therapy device; a mounting portion attached to the holding portion; pins attached to the mounting portion, the pins extending away from the holding portion of the body, the pins defining a cavity for receiving the pins; and magnets disposed within the cavity of the pins. 1. A magnetic therapy device for treating a body part, comprising: a holding portion for controlling the magnetic therapy device; a mounting portion attached to the holding portion; first, second and third pins attached to the mounting portion, the first, second and third pins extending away from the holding portion, the first pin having a first cavity, the second pin having a second cavity, the third pin having a third cavity; and first, second and third magnets, the first magnet disposed within the first cavity of the first pin, the second magnet disposed within the second cavity of the second magnet, the third magnet disposed within the third cavity of the third pin. 14. A method of treating a body part with a magnetic field, the method comprising the steps of: disposing two protrusions of a magnetic therapy device on a surface of a body part being treated so that two magnetic fields of two magnets disposed inside the two protrusions which intersect simultaneously penetrate the surface of the body part being treated. 2. A method of treating a body part with a magnetic field, the method comprising the steps of: disposing two protrusions of a magnetic therapy device on a surface of a body part being treated so that two magnetic fields of two magnets disposed inside the two protrusions which intersect simultaneously penetrate the surface of the body part being treated; and moving the intersecting magnetic fields over the surface of the body part being treated. The matched language is shown as underlined sections, and italicized sections are differences in wording. As noted in the table above, claim 1 of the patent discloses all the elements of present claim 1. The italicized sections show that the patent recites a more specific description while the present application recites a more general limitation (first, second and third pins and magnets vs pins and magnets). Thus, claim 1 of US 12,053,639 discloses a species that anticipates the present genus claim. Regarding claim 14, claim 2 of US 12,053,639 discloses all elements of claim 14 and further recites additional components, which makes it a species that anticipates the present genus claim. Claims 1-16 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 and 14 of U.S. Patent No. 10,688,311. Although the claims at issue are not identical, they are not patentably distinct from each other because US 10,688,311 disclose species that anticipates the present genus claims. The mapping of the claims is shown below. Present Application US 10,688,311 1. A magnetic therapy device for treating a body part, comprising: a holding portion for controlling the magnetic therapy device; a mounting portion attached to the holding portion; pins attached to the mounting portion, the pins extending away from the holding portion of the body, the pins defining a cavity for receiving the pins; and magnets disposed within the cavity of the pins. 1. A magnetic therapy device for treating a body part, comprising: a body including: a holding portion for gripping by a user's hand; a mounting portion attached to the holding portion; first, second and third pins attached to the mounting portion, the first, second and third pins extending away from the holding portion of the body, the first pin having a first cavity, the second pin having a second cavity, the third pin having a third cavity; and first, second and third magnets, the first magnet disposed within the first cavity of the first pin, the second magnet disposed within the second cavity of the second pin, the third magnet disposed within the third cavity of the third pin. 14. A method of treating a body part with a magnetic field, the method comprising the steps of: disposing two protrusions of a magnetic therapy device on a surface of a body part being treated so that two magnetic fields of two magnets disposed inside the two protrusions which intersect simultaneously penetrate the surface of the body part being treated. 14. A method of treating a body part with a magnetic field, the method comprising the steps of: touching two pins of a magnetic therapy device on a surface of a body part being treated; allowing two magnetic fields of two magnets disposed inside the two pins which intersect to penetrate a location of the surface of the body part being treated at the same time; and moving the intersecting magnetic field over the surface of the body part being treated. Regarding present claim 1, as noted in the table above, claim 1 of the patent discloses all the elements of present claim 1. The italicized sections show that the patent recites a more specific description while the present application recites a more general limitation (holding portion for gripping; first, second, and third pins; and first, second, and third, magnets vs holding portion for controlling; pins; and magnets). Claim 1 of US 10,688,311 also recites few additional components. Thus, claim 1 of US 10,688,311 discloses a species that anticipates the present genus claim. Regarding present claim 14, claim 14 of the present application recites a singular step of disposing protrusions in a manner with an intended result of the magnetic fields intersecting (a more generic step) while claim 14 of US 10,688,311 recites two active steps (touching the pins and allowing the magnetic fields to intersect). The patent in this case discloses a more specific instance as “touching two pins” and “allowing two magnetic fields...intersect” is more specific than “disposing two protrusions” with an intended result of magnetic fields intersecting simultaneously. Furthermore, claim 14 of the patent discloses the additional step of moving the magnetic field. Thus, claim 14 of US 10,688,311 discloses a species that anticipates the present genus claim. The limitations of present claim 2 are disclosed by claim 2 of US 10,688,311. The limitations of present claim 3 are disclosed by claim 4 of US 10,688,311. The limitations of present claim 4 are disclosed by claim 3 of US 10,688,311. The limitations of present claim 5 are disclosed by claim 5 of US 10,688,311. The limitations of present claim 6 are disclosed by claim 6 of US 10,688,311. The limitations of present claim 7 are disclosed by claim 7 of US 10,688,311. The limitations of present claim 8 are disclosed by claim 8 of US 10,688,311. The limitations of present claim 9 are disclosed by claim 9 of US 10,688,311. The limitations of present claim 10 are disclosed by claim 10 of US 10,688,311. The limitations of present claim 11 are disclosed by claim 11 of US 10,688,311. The limitations of present claim 12 are disclosed by claim 12 of US 10,688,311. The limitations of present claim 13 are disclosed by claim 13 of US 10,688,311. The limitations of present claim 15 are disclosed by claim 15 of US 10,688,311. The limitations of present claim 16 are disclosed by claim 16 of US 10,688,311. Claim 17 is rejected on the ground of nonstatutory double patenting as being unpatentable over claim 15 of U.S. Patent No. 10,688,311 in view of US 2016/0051827 (Ron Edoute et al., hereinafter Edoute). For claim 17, the limitation of claim 15 are disclosed by species claim 15 of US 10,688,311. However, the duration of the moving step is not disclosed. Edoute discloses a method that applies electromagnetic fields for skin rejuvenation. Edoute states in paragraph 313 that the application can last from 0.01 to 100 minutes. Edoute performed a study where each side receives a 20-minute application and noticed skin improvements (paragraphs 336-375). While Edoute does not state that the application is performed for 15 minutes. Applicant’s specification states that the application can have an interval of 5 to 30 minutes. Thus, it would have been obvious to one of ordinary skill in the art before the filing date of the claimed invention to optimize the therapy duration of US 10,688,311 to arrive at the claimed duration as noted by Edoute because a clinician is motivated to optimize therapy parameters to obtain ideal patient results. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 10, and 13 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 6,338,347 (Chung). Regarding claim 1, Chung discloses a device to aid with blood circulation (figures 2-4; column 2, line 1-column 3, line 6) with the following components: a holding portion for controlling the device (cover shell, 20); a mounting portion attached to the holding portion (contact circuit board, 22); pins (240) attached to the mounting portion and extending away from the holding portion (see figures 2-4; pins extend down away from the circuit board), the pins defining a cavity for receiving the pins (as shown in figures 2-4; the singular large cavity receives the pins); and magnets (231) disposed within the cavity of the pins (figures 2-4 show the cavity containing multiple magnets). Regarding claim 10, Chung discloses the limitation of claim 1. In addition, the cover shell (20) can be considered as a upper dome shaped surface as it shares shape elements of a dome. Regarding claim 13, Chung discloses the limitations of claim 1. Chung further shows the presence of springs (232) in figures 3 and 4 that are disposed within the cavity (column 2, lines 9-33). Due to the 112 issues of the claim Chung would meet the claimed limitation. Claim(s) 14 and 16 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2016/0051827 (Ron Edoute et al., hereinafter Edoute). Regarding claim 14, Edoute discloses a method that uses a device used for skin rejuvenation (title; abstract; figures 1C, 1D, 5-12; paragraphs 150-369). Figures 1C and 1D show the exterior and the interior of the device. The device has at least two protrusions/electrodes (41) with an associated coil magnet (42) (paragraphs 98, 227-232, 274; figure 1C shows that the coils are in the protrusions) and is placed on a patient’s skin surface (paragraph 196). It is also noted that the claim does not specify how the fields intersect. Based on the configuration of the coils (note that the coils in 1C have a similar configuration to the coils shown in figures 5 and 6), the magnetic fields of the coils would naturally intersect in some manner and produce a magnetic field that would penetrate the surface of the body part being treated. Regarding claim 16, Edoute discloses the limitations of claim 14. The claim does not give any guidance as to how to allow the weight of the device to apply pressure to the surface of the body part. Thus, any placement of the device on the skin surface as noted in paragraph 196 can be considered as allowing a weight of the device to apply pressure to the surface of the body part being treated. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 6 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 6,338,347 (Chung) as applied to claim 1 above, and further in view of US 2007/0129745 (Suh et al., hereinafter Suh). Regarding claim 6, Chung discloses the limitations of claim 1 but does not give any information about the materials of the pins. In a related area, Suh discloses a needle device that is used to facilitate blood circulation (abstract; paragraphs 16-28; figure 4). Paragraph 23 states that the needle is made of STS 304, a type of stainless steel commonly used in healthcare and medical environments. Due to the 112 issues of the claim, Suh would meet the material limitation. Thus, it would have been obvious to one of ordinary skill in the art before the filing date of the claimed invention to modify the device of Chung to use STS 304 stainless steel as taught by Suh as it is one of several stainless steels used in healthcare and medical environments. Conclusion The examiner notes that, though no art has been applied against claims 2-5, 7-9, 11, 12, 15, and 17 at this time, they are not presently allowable. The question of prior art will be revisited upon resolution of the numerous issues noted above. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSHUA DARYL DEANON LANNU whose telephone number is (571)270-1986. The examiner can normally be reached Monday-Thursday 8 AM - 5 PM, Friday 8 AM -12 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Charles Marmor can be reached at (571) 272-4730. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHARLES A MARMOR II/Supervisory Patent Examiner Art Unit 3791 /JOSHUA DARYL D LANNU/Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Jul 01, 2024
Application Filed
Aug 13, 2024
Response after Non-Final Action
Oct 23, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788938
METHOD AND SYSTEM OF A PET PRODUCT WITH TRANSCUTANEOUS VIBRATORY OUTPUT
5y 1m to grant Granted Nov 10, 2026
Patent 12778702
DEVICE FOR DESTROYING CELL STRUCTURES WITHOUT DAMAGING THEIR SURROUNDINGS
3y 6m to grant Granted Nov 03, 2026
Patent 12766332
Magnetic Stimulation With Random Variable Pulsed Intervals
4y 10m to grant Granted Oct 20, 2026
Patent 12758738
CUSTOMIZED-TYPE SLEEP MANAGEMENT METHOD AND SYSTEM
4y 11m to grant Granted Oct 13, 2026
Patent 12758739
SYSTEMS AND METHODS FOR REDUCING INSOMNIA-RELATED SYMPTOMS
4y 2m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
82%
Grant Probability
99%
With Interview (+23.9%)
Low
PTA Risk
Based on 965 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month